ScottKurtzmanMD

General Surgery • Middlebury, CT

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Frank H Netter SOM and University of Connecticut

Join to view full profile

Dr. Kurtzman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kurtzman's full profile

Already have an account?

Office
1625 Straits Tpke
Suite 200
Middlebury, CT 06762
Phone+1 203-568-2929

Fax+1 203-568-2921

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1985 - 1988
Clinical Center at the National Institutes of HealthResidency, Surgery, 1983 - 1985
University of MarylandResidency, Surgery, 1981 - 1983
Albany Medical CollegeClass of 1981

Certifications & Licensure

NY State Medical License 1988 - Present
CT State Medical License 1990 - 2025
NJ State Medical License 1985 - 1991
American Board of Surgery Surgery

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Fellow (FACS) American College of Surgeons

Clinical Trials

Computed Tomography Laser Mammography Breast Imaging Device Start of enrollment: 2015 Oct 01
Unknown status

Publications & Presentations

PubMed

Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic?
Marie L Fefferman, Kelley Chan, Joseph Cotler, Danielle M Thompson, Richard J Bleicher
Breast Cancer Research and Treatment. 2025-01-26
1 citations
Small Bowel Follow-Through: Treatment for Small Bowel Obstruction or Delaying the Inevitable?
Mohammad Ali, Daniel R Slack, Emery Edmondson, Richard Feinn, Scott H Kurtzman
Cureus. 2023-12-01
13 citations
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
Rachel Hae-Soo Joung, Timothy W Mullett, Scott H Kurtzman, Sarah Shafir, James B Harris
JAMA Network Open. 2022-11-01

Press Mentions

New Breast Cancer Standards Emphasize Individualized Patient CareApril 19th, 2023
National Quality Improvement Initiative Led by the American College of Surgeons Successfully Helped Address Pandemic-Related Cancer Screening DeficitsNovember 16th, 2022
After Mastectomy Some Women Don’t Want to Replace Their BreastsJune 11th, 2022
Join now to see all

Grant Support

Clinical Trial: NSABP P-2: STARNational Center For Research Resources2008
NSABP Treatment B21National Center For Research Resources2007
Nsabp- B33National Center For Research Resources2006–2007
NSABP P-2: STARNational Center For Research Resources2006–2007
NSABP B-38National Center For Research Resources2006–2007
NSABP B-28National Center For Research Resources2006–2007
NSABP Co-7National Center For Research Resources2005–2007
NSABP B-35National Center For Research Resources2005–2007
NSABP B-31National Center For Research Resources2005–2007
NSABP B-27National Center For Research Resources2005–2007
Nsabp-B34National Center For Research Resources2004–2007
NSABP P-1 TrialNational Center For Research Resources2006
NSABP B23 AC VS CMFNational Center For Research Resources2005
NSABP Protocol P-2: STARNational Center For Research Resources2004–2005
Acsog-Z0010National Center For Research Resources2004–2005
Trial To Determine The Worth Of Tamoxifen For Preventing Breast CancerNational Center For Research Resources1996–2005
Worth Of Tamoxifen For Preventing Breast CancerNational Center For Research Resources2004
HedaNational Center For Research Resources2004
NSABP Treatment TrialsNational Center For Research Resources1997–2002
NSABP P2--Tamoxifen &Raloxifene For Prevention Of Breast CancerNational Center For Research Resources2000
NSABP B28--Taxol/Adriamycin/Cyclophosphamide In Breast CancerNational Center For Research Resources2000
NSABP B27.1--Tumor Biomarkers In Breast CancerNational Center For Research Resources2000
NSABP B23--Adriamycin/Cyclophosamide/Methotrexate/Fluorouracil In Breast CancerNational Center For Research Resources2000
NSABP B23--Ac Versus CMF In Node Negative Breast CancerNational Center For Research Resources2000
NSABP B1-65--Menstrual Cycle &Surgical Treatment Of Breast CancerNational Center For Research Resources2000
NSABP B-27--Preoperative Doxorubicin/Cyclophosphamide/Docetaxel In Breast CancerNational Center For Research Resources2000